LEXINGTON, Mass., Dec. 19 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced that its three-year contract covering its critical care portfolio with HealthTrust Purchasing Group, LP (HealthTrust), a leading group purchasing organization, has been extended to all Consorta, Inc. members. Consorta, another leading healthcare group purchasing organization, and HealthTrust finalized an agreement that established Consorta as the sixth equity owner of HealthTrust, effective April 18, 2007. The membership of the combined organization is comprised of over 1,300 acute care facilities, including five of the ten largest healthcare systems in the country.
The contract covers IL's portfolio of critical care analyzers, reagents, consumables and service, including IL's flagship products, the new GEM(R) Premier(TM) 4000 and the GEM Premier 3000 analyzers for blood gas, electrolyte and metabolite testing. Additionally, the GEM Premier 4000 includes integrated CO-Oximetry and GEMweb(R) Plus, unique information management software for complete control of all networked analyzers. Both GEM Premier analyzers feature Intelligent Quality Management (iQM(R)), IL's patented, real-time, automated, continuous quality assurance system that helps ensure the quality of every test result while reducing costs and saving time. iQM, coupled with its cartridge-based technology and ease of use, allows the GEM Premier analyzers to be used throughout the hospital, at the point of care and in the lab. The flexibility of the many cartridge sizes and menus makes the GEM Premier analyzers ideally suited to meet the needs of HealthTrust's diverse hospital market.
"Customer satisfaction with our products and services is exceptionally high. HealthTrust and IL enjoy a very positive relationship, which will continue to grow with the addition of the entire Consorta membership," said Brian Durkin, Director of Sales and National Accounts at IL. "We continually strive to help our customers deliver the highest quality patient care and look forward to providing HealthTrust and Consorta members with the best in critical care diagnostics."
Instrumentation Laboratory (http://www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM product offerings, part of the critical care line, include the new GEM Premier 4000 analyzer with Intelligent Quality Management (iQM(R)), GEM Premier 3000 analyzer, GEM OPL(TM), a portable whole blood CO-Oximeter and the GEM PCL Plus, a portable coagulation analyzer. IL's hemostasis portfolio includes the ACL TOP(R), a fully automated, high-productivity analyzer and the ACL ELITE, the latest addition to the ACL family. IL also offers the HemosIL(R) line of reagents. IL is based in Lexington, Massachusetts.
HealthTrust Purchasing Group, LP (HealthTrust), headquartered in Brentwood, Tennessee, is a group purchasing organization that supports not-for-profit and for-profit acute care hospitals, ambulatory surgery centers, alternate care sites, and physician practices. With an annual purchasing volume by its members of more than $13 billion, HealthTrust is committed to obtaining the best price for clinically-recommended products, ensuring their timely delivery and continuously evaluating and improving services to the patients, physicians and clinicians they serve. For more information, please visit http://www.healthtrustpg.com.
|SOURCE Instrumentation Laboratory|
Copyright©2007 PR Newswire.
All rights reserved